NCT06008171

Patient Decision Aid for the Treatment of Actinic Keratosis

• Status: Active Not Recruiting
• Phase: N/A
• Study type: Interventional
• Enrollment: 106 (estimated)
• Sponsor: Maastricht University Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

This study evaluates whether a Patient Decision Aid for the field-directed treatment of actinic keratosis has an effect on shared decision making and patient satisfaction.

Detailed description

Actinic keratosis is the most common epithelial precancerous lesion among the Caucasian race. With an increase in prevalence worldwide due to an aging population and rise of ultraviolet exposure actinic keratosis are among the most frequently encountered skin lesions in clinical practice. There are many therapeutic modalities for the treatment of actinic keratosis, depending on multiple factors such as distribution, characteristics, patient preference, side effects, availability and costs. Treatment options can be divided into: lesion directed therapy en field directed therapy. A Patient Decision Aid for field-directed therapies for actinic keratosis may attribute to better shared-decision making and patient satisfaction which on their part may benefits treatment compliance and health outcomes and may lead to fewer disputes between patients and doctors.

Conditions

• Actinic Keratoses
• Patient Decision Aid

Interventions

Type	Name	Description
OTHER	Patient Decision Aid	A designed tool (by us) that help patients and providers talk and decide together about field-directed treatment options for actinic keratosis.

Timeline

• Start date: 2022-11-01
• Primary completion: 2024-08-01
• Completion: 2025-12-01
• First posted: 2023-08-23
• Last updated: 2025-04-04

Locations

1 site across 1 country: Netherlands